Healthcare Associated Infections (HAI)

Fidaxomicin and vancomycin are effective first-line therapies for Clostridium difficile, yet fidaxomicin may be more effective for achieving sustained symptomatic cure.

A team of physicians yields surprising findings in an elderly patient in shock with seizures.

While we are focused on antimicrobial resistance to drugs, we may be missing another microbial menace.

Requiring reporting of health care-associated infections for reimbursement is a lot messier than one might think.

Alternative agents are often broader spectrum than ß-lactams, subjecting patients to collateral damage and subsequent selection for resistant organisms and Clostridium difficile.

Study suggests that clinicians should perform confirmatory allergy testing on patients with reported penicillin allergies as an important feature of antimicrobial stewardship.

Oritavancin is a useful antimicrobial option to help clinicians manage MRSA infections and other serious GPC infections in patients with cancer, including in those at the end-of-life.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

The FDA seeks a permanent injunction against a company selling unapproved hand sanitizers that claim to be effective against infections from several pathogens.

Researchers from Vanderbilt University Medical Center determine the metabolic pathway that S aureus uses to survive in bones.

McGill University researchers find that infection with C difficile might more likely be linked to infected than colonized donors.